<DOC>
	<DOCNO>NCT01608204</DOCNO>
	<brief_summary>The correlation Busulfan Pharmacokinetics AML transplant patient GST ( A1 , T1 , M1 P1 ) , MDR-1 genetic profile . If pre-genetic test gene utilized biomarkers SOS and/or HGVHD . This study interventional study check GST gene MDR-1 gene</brief_summary>
	<brief_title>Busulfan Pharmacokinetic Analysis GST Pharmacogenetic Profile Adults Undergoing Hematological Stem Cell Transplantation</brief_title>
	<detailed_description>BU level largely unpredictable , patient often expose toxic effect inappropriate drug regimen dose modification make . Although importance TDM emphasize , entail trial error allow pre- treatment dose optimization . This study , provide integration genetic pharmacokinetic data analysis patient precondition HSCT high dose oral BU , aim define biomarkers predictive poor BU metabolism clearance prevent potential drug toxicity.This study interventional study , investigate GST MDR-1 gene correlation `` routine '' Busulfan AUC do preparative regimen HSCT AML patient .</detailed_description>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Acute Myeloid Leukemia clinically select HSCT accord know protocol . Unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>67 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Busulfan</keyword>
	<keyword>Polymorphism</keyword>
	<keyword>GST</keyword>
	<keyword>MDR-1 ( p-Glycoprotein )</keyword>
	<keyword>Acute Myeloid Leukemia adult patient</keyword>
</DOC>